The rate of growth of the script numbers has not, in my opinion, been enough even to justify the revenue growth expectations embedded in the price of the stock. The past script numbers have actually been a restraint on the price of the stock. I believe this script report clearly shows the acceleration in scripts which is the beginning of the hockey stick. This start is driven by the ADCOM results. However, scripts will have to accelerate very dramatically to drive even higher expectations for future revenues. The ultimate revenue scenario will only become clear with the actual label wording and the subsequent scripts boom.
I hope that Canada approves today with a broad label as some expect. It would be for the best of the Canadian socialized health system to do so, and Canada may be that progressive.
News 
Market Data 
Discover 
